Subretinal transplantation with human umbilical cord-derived mesenchymal stem cells delays retinal degeneration in royal college of surgeons rats

      Retinitis pigmentosa and age-related macular degeneration represent the main causes of blindness worldwide. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) are a promising candidate for regenerative therapy due to its advantages over other cell types. This study investigates the effect of subretinal injection of hUC-MSCs on retinal functional electroretinographic (ERG) activity and retinal structure of Royal College of Surgeons (RCS) rats.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect